| Similar Articles |
|---|
 |
National Defense
November 2005
Margaret Davidson |
Biodefense Experts: Vaccines `At a Crossroads' Many of the companies seeking government funds for biodefense work are small firms with no experience in bringing a drug to market. And they face a significant challenge.   |
National Defense
June 2007
Breanne Wagner |
Agencies Scramble to Create Vaccine Market Defense and Homeland Security are pursuing disparate vaccination programs to combat different needs for military and civilian populations. |
Popular Mechanics
January 15, 2010
Joe Pappalardo |
Researchers Decry Proposed Rules to Secure Bio Research Labs New proposals put forward by Congress and supported by a recently released federal study are roiling researchers at labs that work with biological agents. |
Chemistry World
June 3, 2015
Rebecca Trager |
Biosafety blunder as US sends live anthrax to labs around world Revelations that the US Department of Defense accidentally shipped live anthrax samples to at least 24 labs in 11 states and two foreign countries has prompted a congressional committee to demand answers. |
Chemistry World
December 24, 2014
Rebecca Trager |
FBI's 2001 anthrax investigation was flawed The scientific evidence that the US Federal Bureau of Investigation relied upon to investigate the October 2001 anthrax attacks was deeply flawed, according to a new report. |
National Defense
June 2011
Eric Beidel |
Industry, Academia Race to Create Drugs Against Biological Warfare On the heels of anthrax comes a string of deadly agents that scientists also fear can be used as weapons and spread with ease. |
Searcher
March 2002
Eva Perkins |
Bioterrorism Resources on the Internet: A Primer What is bioterrorism? Which organizations and governmental agencies publish in this area? Using the power of the beloved Internet, one can easily and quickly access a wealth of information. Here's how to do it... |
Bio-IT World
November 14, 2003
Jason B. Lee |
Profiting from the BioShield How can software developers ensure a share of the tremendous biodefense funding available to bio-IT companies -- and what are the risks? |
National Defense
July 2009 |
Readers Sound Off on Recent Stories 7 Deadly Myth article draws comment. |
National Defense
November 2004
Joe Pappalardo |
Security Beat Local Responders Linked With Coast Guard Units... Russian Horror Highlights U.S. School Security... Public Would Ignore Authorities in Terror Event... Fort Detrick Begins Bio-Defense Additions... etc. |
Bio-IT World
April 15, 2003
James Golden |
Sequence Signatures and Homeland Security The bio-IT community has a unique opportunity to contribute to national biodefense. |
Chemistry World
September 11, 2014
Rebecca Trager |
NIH audit turns up plague bacteria and ricin US National Institutes of Health initiated a sweep of its facilities to uncover any improperly stored dangerous agents, toxins or hazardous biological materials. That search has now revealed several instances of lax oversight. |
Bio-IT World
September 16, 2004
Zachary Zimmerman |
The Dark Side of Project BioShield Despite the uncertainties, an estimated 100 biopharma companies are developing anti-terror technologies. But they should examine both sides of Project BioShield before considering product development. |
Salon.com
October 9, 2001
Suzy Hansen |
Plague fears A bioterrorism expert talks about the wicked ways of anthrax and the even deadlier potential scourge of smallpox... |
Mother Jones
Jan/Feb 2002
Bill Hogan |
A Biodefense Boondoggle As pharmaceutical companies line up for multimillion-dollar contracts to make bioterrorism vaccines, some question whether the industry is up to the job... |
Pharmaceutical Executive
December 1, 2005
Anthony Tao |
The Avian Few: Is it Too Late for Pharma to Re-enter the Vaccine Fray? Small profit margins and high litigation risks drove most companies out of the vaccine business decades ago. As a possible pandemic looms, pharma re-enters the fray. Is it too late? |
American Family Physician
May 1, 2003
O'Brien & Halverson |
Recognition and Management of Bioterrorism Infections Familiarity with the infectious agents of highest priority can expedite diagnosis and initial management, and lead to a successful public health response to such an attack. |
National Defense
August 2005
Joe Pappalardo |
Pentagon Spurs its Biological And Chemical Defense Programs The Pentagon is trying to buttress the military's defensive posture against biological and chemical weapons by focusing on the development of advanced vaccines and improved therapeutics. A surge in money is fueling this effort. |
National Defense
February 2009
Magnuson & Rusling |
Senators May Seek Life Science Lab Security Regulations Life science laboratories, and similar facilities are proliferating throughout the world. Security is lax at many of them -- including the United States. Background checks for those working in the labs are spotty. |
Salon.com
October 26, 2001
Chris Colin |
Is there an anthrax doctor in the house? Scoops are few and desperation is catching at the annual conference of the Infectious Diseases Society of America... |
Popular Mechanics
May 2009 |
Virus Hunters: Inside Maryland's New Biosafety Level 4 Lab The integrated research facility at Fort Detrick, Md., doesn't look menacing. |
CIO
June 1, 2003
Sarah D. Scalet |
Immune Systems Health officials are working toward a sophisticated IT network that could detect the early warning signs of bioterrorism, but formidable obstacles remain. |
Pharmaceutical Executive
July 3, 2007
Jill Wechsler |
Washington Report: Vaccines for Everyone New vaccines can be good business and a huge boon to public health. But the challenge is to establish prices that ensure global access, and to bring necessary medications to third-world countries. |
Bio-IT World
June 15, 2003
Malorye Branca |
A View to a Kill Genomics, bioinformatics, and novel laboratory techniques are converging to boost vaccine research against a new wave of emerging diseases, natural and man-made. Now, will in silico modeling ramp up sufficiently to further speed vaccine discovery? |
| AskMen.com |
Vaccine Helps Prevent HIV For the first time, an experimental vaccine has prevented infection with the AIDS virus, a watershed event in the deadly epidemic and a surprising result. |
Bio-IT World
February 2006
Steven Withrow |
Northrop Grumman, UTSW Boost Biodefense Resources Fighting bioterrorism and infectious disease is not part of the usual IT job description. But Northrop Grumman's IT sector routinely moves beyond the usual, having garnered two multimillion-dollar bioinformatics development contracts since 2004. |
